NCT00602667 · OUTCOME
Number of Successful Collections for Frozen and Fixed Tumor Samples
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Based on samples obtained at the time of initial surgery or repeat surgery prior to treatment
What was measured
Successful collections will be defined as the number of patients who have frozen/fixed tumor samples available.
Analysis population: All eligible patients enrolled (n=290) were included in this analysis. The numbers of patients with pre-study samples were considered for these results.
Groups in this outcome
Low-Risk Group
Patients with gross total resection (GTR)/no evidence of metastatic disease (M0) medulloblastoma, nodular desmoplastic or high grade glioma histology will receive induction chemotherapy and low-risk therapy.
Intermediate-Risk Group
Patients with (M0) medulloblastoma or nodular desmoplastic histology with less than a GTR, other histologic diagnoses with no metastatic disease, will receive induction chemotherapy and intermediate-risk therapy.
High-Risk Group
Patients with central nervous system (CNS) metastatic disease will receive induction chemotherapy and high-risk therapy.
| Group | Source count |
|---|---|
| Low-Risk Group | 57 |
| Intermediate-Risk Group | 156 |
| High-Risk Group | 77 |
Reported measurements
Number with frozen tumor tissue
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Low-Risk Group | 27 | Not reported | Not reported | Not reported | Not reported |
| Intermediate-Risk Group | 73 | Not reported | Not reported | Not reported | Not reported |
| High-Risk Group | 32 | Not reported | Not reported | Not reported | Not reported |
Number with fixed tumor tissue
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| Low-Risk Group | 54 | Not reported | Not reported | Not reported | Not reported |
| Intermediate-Risk Group | 153 | Not reported | Not reported | Not reported | Not reported |
| High-Risk Group | 71 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- classes
- categories
- measurements
- group Id
- OG000
- value
- 27
- group Id
- OG001
- value
- 73
- group Id
- OG002
- value
- 32
- title
- Number with frozen tumor tissue
- categories
- measurements
- group Id
- OG000
- value
- 54
- group Id
- OG001
- value
- 153
- group Id
- OG002
- value
- 71
- title
- Number with fixed tumor tissue
- denoms
- counts
- group Id
- OG000
- value
- 57
- group Id
- OG001
- value
- 156
- group Id
- OG002
- value
- 77
- units
- Participants
- description
- Successful collections will be defined as the number of patients who have frozen/fixed tumor samples available.
- groups
- description
- Patients with gross total resection (GTR)/no evidence of metastatic disease (M0) medulloblastoma, nodular desmoplastic or high grade glioma histology will receive induction chemotherapy and low-risk therapy.
- id
- OG000
- title
- Low-Risk Group
- description
- Patients with (M0) medulloblastoma or nodular desmoplastic histology with less than a GTR, other histologic diagnoses with no metastatic disease, will receive induction chemotherapy and intermediate-risk therapy.
- id
- OG001
- title
- Intermediate-Risk Group
- description
- Patients with central nervous system (CNS) metastatic disease will receive induction chemotherapy and high-risk therapy.
- id
- OG002
- title
- High-Risk Group
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- All eligible patients enrolled (n=290) were included in this analysis. The numbers of patients with pre-study samples were considered for these results.
- reporting Status
- POSTED
- time Frame
- Based on samples obtained at the time of initial surgery or repeat surgery prior to treatment
- title
- Number of Successful Collections for Frozen and Fixed Tumor Samples
- type
- SECONDARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle